Emily A. Hemann

2.5k total citations
29 papers, 831 citations indexed

About

Emily A. Hemann is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Emily A. Hemann has authored 29 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 12 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Emily A. Hemann's work include Immune Cell Function and Interaction (12 papers), interferon and immune responses (11 papers) and Influenza Virus Research Studies (11 papers). Emily A. Hemann is often cited by papers focused on Immune Cell Function and Interaction (12 papers), interferon and immune responses (11 papers) and Influenza Virus Research Studies (11 papers). Emily A. Hemann collaborates with scholars based in United States, United Kingdom and Canada. Emily A. Hemann's co-authors include Michael Gale, Ram Savan, Kevin L. Legge, Richard Green, Ryan A. Langlois, Julie Turnbull, Sang‐Moo Kang, Adriana Forero, Courtney Wilkins and Zeb R. Zacharias and has published in prestigious journals such as Nature Communications, Immunity and Nature Immunology.

In The Last Decade

Emily A. Hemann

27 papers receiving 826 citations

Peers

Countries citing papers authored by Emily A. Hemann

Since Specialization

Citations

This map shows the geographic impact of Emily A. Hemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Hemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Hemann more than expected).

Fields of papers citing papers by Emily A. Hemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Hemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Hemann. The network helps show where Emily A. Hemann may publish in the future.

Co-authorship network of co-authors of Emily A. Hemann

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Hemann. A scholar is included among the top collaborators of Emily A. Hemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Hemann. Emily A. Hemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aiolos restricts the generation of antigen-inexperienced, virtual memory CD8+ T cells in mice 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Qiaoke Gong, (unknown), (unknown), Kaitlin A. Read, Jacob S. Yount, Gang Xin, Adriana Forero, Hazem E. Ghoneim, Patrick L. Collins, Emily A. Hemann, Kenneth J. Oestreich	0
2	Targeting the MEK1/2 pathway to combat Staphylococcus aureus infection and inflammation in cystic fibrosis 2025 ·mBio ·(unknown), (unknown), (unknown), Yiwei Liu, Daniel J. Wozniak, Kymberly M. Gowdy, Jean Charron, Susan E. Birket, Megan R. Kiedrowski, Emily A. Hemann, Matthew E. Long	1
3	IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN 2024 ·JCI Insight ·(unknown), Parker Denz, Adam D. Kenney, Najmus Mahfooz, (unknown), Qiaoke Gong, Richard Robinson, Matthew E. Long, Adriana Forero, Jacob S. Yount, Emily A. Hemann	1
4	Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation 2024 ·Nature Communications ·(unknown), (unknown), Ashley Zani, (unknown), (unknown), (unknown), Adam D. Kenney, (unknown), Lizhi Zhang, Parker Denz, Adrian C. Eddy, Amal O. Amer, Richard Robinson, Chuanxi Cai, Jianjie Ma, Emily A. Hemann, Adriana Forero, Jacob S. Yount	21
5	MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection 2024 ·Frontiers in Cellular and Infection Microbiology ·(unknown), (unknown), (unknown), Katherine B. Hisert, W. Conrad Liles, Anne M. Manicone, Emily A. Hemann, Matthew E. Long	7
6	Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice 2023 ·EMBO Reports ·Adam D. Kenney, Ashley Zani, (unknown), Adrian C. Eddy, Xiao‐Liang Wang, (unknown), Mijia Lu, (unknown), Jacob E. Kohlmeier, Mehul S. Suthar, Emily A. Hemann, Jiànróng Lǐ, Mark E. Peeples, Luanne Hall‐Stoodley, Adriana Forero, Chuanxi Cai, Jianjie Ma, Jacob S. Yount	18
7	Reducing off-target drug accumulation by exploiting a type-III interferon response 2023 ·Journal of Controlled Release ·(unknown), (unknown), Emily A. Hemann, Thomas J. Anchordoquy	4
8	A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity 2023 ·The Journal of Immunology ·Emily A. Hemann, Megan Knoll, Courtney Wilkins, Caroline Subra, Richard Green, Adolfo Garcı́a-Sastre, Paul G. Thomas, Lydie Trautmann, Reneé C. Ireton, Yueh–Ming Loo, Michael Gale	15
9	RIG-I–like Receptor Regulation of Immune Cell Function and Therapeutic Implications 2022 ·The Journal of Immunology ·(unknown), (unknown), Adriana Forero, Emily A. Hemann	12
10	SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing 2020 ·The Journal of Infectious Diseases ·Jennifer A. Rathe, Emily A. Hemann, Julie Eggenberger, Zhaoqi Li, Megan Knoll, Caleb Stokes, Tien-Ying Hsiang, Jason Netland, Kennidy K. Takehara, Marion Pepper, Michael Gale	12
11	RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication 2020 ·PLoS Pathogens ·Alison M. Kell, Emily A. Hemann, Julie Turnbull, Michael Gale	27
12	STING is required for host defense against neuropathological West Nile virus infection 2019 ·PLoS Pathogens ·(unknown), Piper M. Treuting, Emily A. Hemann, Katharina Esser‐Nobis, Annelise G. Snyder, Jessica B. Graham, Brian P. Daniels, Courtney Wilkins, Jessica M. Snyder, (unknown), Andrew Oberst, Jennifer M. Lund, Michael Gale	34
13	RIG-I-like receptors direct inflammatory macrophage polarization against West Nile virus infection 2019 ·Nature Communications ·Amy E.L. Stone, Richard Green, Courtney Wilkins, Emily A. Hemann, Michael Gale	50
14	Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons 2019 ·Immunity ·Adriana Forero, Snehal Ozarkar, Hongchuan Li, (unknown), Emily A. Hemann, Marija S. Nadjsombati, Matthew R. Hendricks, Lomon So, Richard Green, Chandra Nath Roy, Saumendra N. Sarkar, Jakob von Moltke, Stephen K. Anderson, Michael Gale, Ram Savan	176
15	Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus 2019 ·Nature Immunology ·Emily A. Hemann, Richard Green, Julie Turnbull, Ryan A. Langlois, Ram Savan, Michael Gale	93
16	Natural Killer Cell Recruitment to the Lung During Influenza A Virus Infection Is Dependent on CXCR3, CCR5, and Virus Exposure Dose 2018 ·Frontiers in Immunology ·(unknown), Emily A. Hemann, Zeb R. Zacharias, Jonathan W. Heusel, Kevin L. Legge	67
17	Interferon Lambda Genetics and Biology in Regulation of Viral Control 2017 ·Frontiers in Immunology ·Emily A. Hemann, Michael Gale, Ram Savan	102
18	Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response 2015 ·Journal of Virology ·Emily A. Hemann, Louisa E. Sjaastad, Ryan A. Langlois, Kevin L. Legge	16
19	Peripheral regulation of T cells by dendritic cells during infection 2014 ·Immunologic Research ·Emily A. Hemann, Kevin L. Legge	3
20	The Magnitude of the T Cell Response to a Clinically Significant Dose of Influenza Virus Is Regulated by TRAIL 2011 ·The Journal of Immunology ·Erik L. Brincks, Prajwal Gurung, Ryan A. Langlois, Emily A. Hemann, Kevin L. Legge, Thomas S. Griffith	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact